Oncogene Seminar Series

Oncogene Seminar Series

Springer Nature

Oncogene

Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far.

The Oncogene Seminar Series features seminars contributed by recently published Oncogene authors whose papers have been identified by the editors as being of particular interest to the journal community. Subscribe to receive updates about upcoming seminars.

Speakers
Community
Prof. Julie Saba
AS
DE
MH
Purva Chavda
FG
NZ
NZ
TV
JA
SR
TI
+8
Oncogene
Oncogene

Seminars in preparation

Brown University

Overcoming Resistance to Programmed Cell Death Protein 1 (PD-1) Blockade with Allogeneic Invariant Natural Killer T-Cells (iNKT)

Matthew Hadfield, Brown University

Published seminars

Newcastle University

Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer

D. Elliott, Newcastle University
Università Cattolica del Sacro Cuore

Epigenetics behind tumor immunology: a mini review

A. Sistigu, Università Cattolica del Sacro Cuore
University of California, San Francisco

AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis

Julie Saba, University of California, San Francisco